A goal in next-generation endoscopy is to develop functional imaging techniques to open up new opportunities for cancer diagnosis. Although spatial and temporal information on hypoxia is crucial for understanding cancer physiology and expected to be useful for cancer diagnosis, existing techniques using fluorescent indicators have limitations due to low spatial resolution and invasive administration. To overcome these problems, we developed an imaging technology based on hemoglobin oxygen saturation in both the tumor and surrounding mucosa using a laser endoscope system, and conducted the first human subject research for patients with aero-digestive tract cancer. The oxygen saturation map overlapped the images of cancerous lesions and indicated highly heterogeneous features of oxygen supply in the tumor. The hypoxic region of the tumor surface was found in both early cancer and cancer precursors. This technology illustrates a novel aspect of cancer biology as a potential biomarker and can be widely utilized in cancer diagnosis.
References
[1]
Bertout JA, Patel SA, Simon MC (2008) The impact of O2 availability on human cancer. Nature Rev. Cancer 8: 967–975. doi: 10.1038/nrc2540
[2]
Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, et al. (1996) Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509–4515.
[3]
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646–674. doi: 10.1016/j.cell.2011.02.013
[4]
Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nature Rev. Cancer 3: 721–732. doi: 10.1038/nrc1187
[5]
Semenza GL (2008) Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life 60: 591–597. doi: 10.1002/iub.93
[6]
Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, et al. (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3: 347–361. doi: 10.1016/s1535-6108(03)00085-0
[7]
Sutherland RM (1998) Tumour hypoxia and gene expression—implications for malignant progression and therapy. Acta Oncol 37: 567–574. doi: 10.1080/028418698430278
[8]
Keith B, Simon MC (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129: 465–472. doi: 10.1016/j.cell.2007.04.019
[9]
Jordan BF, Runquist M, Raghunand N, Baker A, Williams R, et al. (2005) Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumour microenvironment in response to inhibition of HIF-1 alpha using PX-478. Neoplasia 5: 475–485. doi: 10.1593/neo.04628
[10]
Goh V, Engledow A, Rodriguez-Justo M, Shastry M, Peck J, et al. (2012) The flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/perfusion CT with histopathologic correlation. J. Nucl. Med 53(5): 687–692. doi: 10.2967/jnumed.111.098525
[11]
Chitneni SK, Palmer GM, Zalutsky MR, Dewhirst MW (2011) Molecular Imaging of Hypoxia. J. Nucl. Med 52: 165–168. doi: 10.2967/jnumed.110.075663
Harada H, Kizaka-Kondoh S, Hiraoka M (2005) Optical imaging of tumour hypoxia and evaluation of efficacy of a hypoxia-targeting drug in living animals. Mol. Imaging 4: 182–193.
[14]
Benaron DA, Parachikov IH, Friedland S, Soetikno R, Brock-Utne J, et al. (2004) Continuous, noninvasive, and localized microvascular tissue oximetry using visible light spectroscopy. Anesthesiology 100: 1469–1475. doi: 10.1097/00000542-200406000-00019
[15]
Maxim PG, Carson JJ, Benaron DA, Loo BW Jr, Xing L, et al. (2005) Optical detection of tumours in vivo by visible light tissue oximetry. Technol. Cancer Res. Treat 4: 227–234.
[16]
Sorg BS, Moeller BJ, Donovan O, Cao Y, Dewhirst MW (2005) Hyperspectral imaging of hemoglobin saturation in tumour microvasculature and tumour hypoxia development. J. Biomed. Opt 10: 4400–4404. doi: 10.1117/1.2003369
[17]
Moy AJ, White SM, Indrawan ES, Lotfi J, Nudelman MJ, et al. (2011) Wide-field functional imaging of blood flow and hemoglobin oxygen saturation in the rodent dorsal window chamber. Microvasc Res 82(3): 199–209. doi: 10.1016/j.mvr.2011.07.004
[18]
Barkun JS, Aronson JK, Feldman LS, Maddern GJ, Strasberg SM, et al. (2009) Evaluation and stages of surgical innovations. Lancet 374: 1089–1096. doi: 10.1016/s0140-6736(09)61083-7
[19]
Brown JM, Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nature Rev. Cancer 4: 437–447. doi: 10.1038/nrc1367
